We are live on ! Find out more
AMED icon

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

398 hedge funds and large institutions have $8.54B invested in Amedisys in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 149 increasing their positions, 144 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital inflows, than outflows

Capital inflows: $501M | Capital outflows: $442M

3% more repeat investments, than reductions

Existing positions increased: 149 | Existing positions reduced: 144

0% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $54.7M

0% more funds holding

Funds holding: 398 → 398 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.31% less ownership

Funds ownership: 89.02% → 88.71% (-0.31%)

19% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 47

Holders
398
Holders Change
–
Holders Change %
0%
% of All Funds
7.01%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
38
Increased
149
Reduced
144
Closed
47
Calls
$54.8​M
Puts
$54.7​M
Net Calls
+$29​K
Net Calls Change
+$20.9​M

AMED Hedge Fund Activity: Q4 2020 in Review

398 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2020, worth a combined $8.54B — up 25% from $6.83B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of AMED and 38 opened new positions — a net loss of 9 holders — while 144 trimmed existing stakes and 149 added.

The largest buyer was Invesco, adding an estimated $94.5M. The largest seller was Assenagon Asset Management, cutting an estimated $46.9M.

  • 398 institutional investors held Amedisys (AMED) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $8.54B of Amedisys stock for Q4 2020, up 25% quarter-over-quarter.
  • 38 funds opened new Amedisys positions in Q4 2020 and 47 closed out, a net change of -9 holders.
  • The largest Amedisys buyer in Q4 2020 was Invesco, an estimated $94.5M added.
  • The largest Amedisys seller in Q4 2020 was Assenagon Asset Management, an estimated $46.9M sold.

Based on aggregated 13F filings for Q4 2020.